Use of DNA methylation profiling in translational oncology

Area of Science:

• Epigenetics and Molecular Oncology

Background:

• DNA methylation is a fundamental epigenetic mechanism regulating gene expression essential for development and cellular homeostasis.
• Aberrant DNA methylation patterns are increasingly recognized in cancer-associated pathways, contributing to tumor initiation and progression.

Purpose of the Study:

• To review the role of DNA methylation in normal cellular function and its dysregulation in cancer.
• To highlight advancements in DNA methylation profiling for cancer diagnosis, prognosis, and treatment monitoring.
• To explore insights into epigenetic-based cancer therapies.

Main Methods:

• Literature review focusing on DNA methylation mechanisms, epigenetic aberrations in cancer, and profiling technologies.
• Analysis of current research on DNA methylation as a biomarker for early detection and clinical outcomes.
• Synthesis of information on epigenetic therapies in oncology.

Main Results:

• DNA methylation is critical for normal cellular function, and its aberrant patterns are hallmarks of cancer.
• DNA methylation profiling offers a powerful tool for early cancer detection, predicting patient outcomes, and monitoring treatment response.
• Epigenetic-based therapies show promise in clinical oncology.

Conclusions:

• Understanding DNA methylation dynamics is crucial for deciphering cancer biology.
• DNA methylation profiling is an indispensable tool in modern oncology, impacting diagnosis, prognosis, and therapeutic strategies.
• Epigenetic modifications represent a promising frontier for novel cancer treatments.